Skip to main content
SpringerLink
Log in

Role of hypoxia-inducible factor-1α in angiogenic–osteogenic coupling

  • Review
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

Angiogenesis and osteogenesis are tightly coupled during bone development and regeneration. The vasculature supplies oxygen to developing and regenerating bone and also delivers critical signals to the stroma that stimulate mesenchymal cell specification to promote bone formation. Recent studies suggest that the hypoxia-inducible factors (HIFs) are required for the initiation of the angiogenic–osteogenic cascade. Genetic manipulation of individual components of the HIF/vascular endothelial growth factor (VEGF) pathway in mice has provided clues to how coupling is achieved. In this article, we review the current understanding of the cellular and molecular mechanisms responsible for angiogenic–osteogenic coupling. We also briefly discuss the therapeutic manipulation of HIF and VEGF in skeletal repair. Such discoveries suggest promising approaches for the development of novel therapies to improve bone accretion and repair.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Brooks M (1971) The blood supply of bone. Buttersworths, London

    Google Scholar 

  2. Tothill P, MacPherson JN (1986) The distribution of blood flow to the whole skeleton in dogs, rabbits and rats measured with microspheres. Clin Phys Physiol Meas 7:117–123

    Article  PubMed  CAS  Google Scholar 

  3. Gross PM, Heistad DD, Marcus ML (1979) Neurohumoral regulation of blood flow to bones and marrow. Am J Physiol 237:H440–448

    PubMed  CAS  Google Scholar 

  4. Gross TS, Clemens TL (1998) Vascular control of bone remodeling. In: Zaidi M, Bittar EE, Abedanjo OA, Huang CLH (eds) Advances in organ biology. JAI, Stamford, pp 137–160

    Google Scholar 

  5. Semenza GL (1999) Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15:551–578

    Article  PubMed  CAS  Google Scholar 

  6. Coolbaugh CC (1952) Effects of reduced blood supply on bone. Am J Physiol 169:26–33

    PubMed  CAS  Google Scholar 

  7. Trueta J, Buhr AJ (1963) The vascular contribution to osteogenesis V. The vasculature supplying the epiphysial cartilage in rachitic rats. J Bone Joint Surg Br 45:572–581

    PubMed  CAS  Google Scholar 

  8. Trueta J, Amato VP (1960) The vascular contribution to osteogenesis. III. Changes in the growth cartilage caused by experimentally induced ischaemia. J Bone Joint Surg Br 42-B:571

    PubMed  CAS  Google Scholar 

  9. Hauge EM, Qvesel D, Eriksen EF, Mosekilde L, Melsen F (2001) Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res 16:1575–1582

    Article  PubMed  CAS  Google Scholar 

  10. Eriksen EF, Eghbali-Fatourechi GZ, Khosla S (2007) Remodeling and vascular spaces in bone. J Bone Miner Res 22:1–6

    Article  PubMed  CAS  Google Scholar 

  11. Semenza GL (2001) HIF-1, O2, and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107:1–3

    Article  PubMed  CAS  Google Scholar 

  12. Semenza GL (2000) HIF-1 and human disease: one highly involved factor. Genes Dev 14:1983–1991

    PubMed  CAS  Google Scholar 

  13. Wenger RH, Rolfs A, Spielmann P, Zimmermann DR, Gassmann M (1998) Mouse hypoxia-inducible factor-1α is encoded by two different mRNA isoforms: expression from a tissue-specific and a housekeeping-type promoter. Blood 91:3471–3480

    PubMed  CAS  Google Scholar 

  14. Pouyssegur J, Dayan F, Mazure NM (2006) Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441:437–443

    Article  PubMed  CAS  Google Scholar 

  15. Berra E, Benizri E, Ginouves A, Volmat V, Roux D, Pouyssegur J (2003) HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. Embo J 22:4082–4090

    Article  PubMed  CAS  Google Scholar 

  16. Min JH, Yang H, Ivan M, Gertler F, Kaelin WG Jr, Pavletich NP (2002) Structure of an HIF-1α -pVHL complex: hydroxyproline recognition in signaling. Science 296:1886–1889

    Article  PubMed  CAS  Google Scholar 

  17. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK (2002) FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 16:1466–1471

    Article  PubMed  CAS  Google Scholar 

  18. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721–732

    Article  PubMed  CAS  Google Scholar 

  19. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L (2006) VEGF receptor signalling—in control of vascular function. Nat Rev Mol Cell Biol 7:359–371

    Article  PubMed  CAS  Google Scholar 

  20. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435–439

    Article  PubMed  CAS  Google Scholar 

  21. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439–442

    Article  PubMed  CAS  Google Scholar 

  22. Kronenberg HM (2003) Developmental regulation of the growth plate. Nature 423:332–336

    Article  PubMed  CAS  Google Scholar 

  23. Provot S, Schipani E (2005) Molecular mechanisms of endochondral bone development. Biochem Biophys Res Commun 328:658–665

    Article  PubMed  CAS  Google Scholar 

  24. Zelzer E, McLean W, Ng YS, Fukai N, Reginato AM, Lovejoy S, D'Amore PA, Olsen BR (2002) Skeletal defects in VEGF120/120 mice reveal multiple roles for VEGF in skeletogenesis. Development 129:1893–1904

    PubMed  CAS  Google Scholar 

  25. Colnot C, Lu C, Hu D, Helms JA (2004) Distinguishing the contributions of the perichondrium, cartilage, and vascular endothelium to skeletal development. Dev Biol 269:55–69

    Article  PubMed  CAS  Google Scholar 

  26. Colnot CI, Helms JA (2001) A molecular analysis of matrix remodeling and angiogenesis during long bone development. Mech Dev 100:245–250

    Article  PubMed  CAS  Google Scholar 

  27. Carlevaro MF, Cermelli S, Cancedda R, Descalzi Cancedda F (2000) Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J Cell Sci 113(Pt 1):59–69

    PubMed  CAS  Google Scholar 

  28. Zelzer E, Glotzer DJ, Hartmann C, Thomas D, Fukai N, Soker S, Olsen BR (2001) Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev 106:97–106

    Article  PubMed  CAS  Google Scholar 

  29. Maes C, Carmeliet P, Moermans K, Stockmans I, Smets N, Collen D, Bouillon R, Carmeliet G (2002) Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech Dev 111:61–73

    Article  PubMed  CAS  Google Scholar 

  30. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N (1999) VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5:623–628

    Article  PubMed  CAS  Google Scholar 

  31. Provot S, Schipani E (2007) Fetal growth plate: a developmental model of cellular adaptation to hypoxia. Ann N Y Acad Sci 1117:26–39

    Article  PubMed  CAS  Google Scholar 

  32. Provot S, Zinyk D, Gunes Y, Kathri R, Le Q, Kronenberg HM, Johnson RS, Longaker MT, Giaccia AJ, Schipani E (2007) Hif-1α regulates differentiation of limb bud mesenchyme and joint development. J Cell Biol 177:451–464

    Article  PubMed  CAS  Google Scholar 

  33. Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M, Johnson RS (2001) Hypoxia in cartilage: HIF-1α is essential for chondrocyte growth arrest and survival. Genes Dev 15:2865–2876

    PubMed  CAS  Google Scholar 

  34. Wang Y, Wan C, Deng L, Liu X, Cao X, Gilbert SR, Bouxsein ML, Faugere MC, Guldberg RE, Gerstenfeld LC, Haase VH, Johnson RS, Schipani E, Clemens TL (2007) The hypoxia-inducible factor α pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 117:1616–1626

    Article  PubMed  CAS  Google Scholar 

  35. Harada S, Nagy JA, Sullivan KA, Thomas KA, Endo N, Rodan GA, Rodan SB (1994) Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest 93:2490–2496

    Article  PubMed  CAS  Google Scholar 

  36. Saadeh PB, Mehrara BJ, Steinbrech DS, Dudziak ME, Greenwald JA, Luchs JS, Spector JA, Ueno H, Gittes GK, Longaker MT (1999) Transforming growth factor-β1 modulates the expression of vascular endothelial growth factor by osteoblasts. Am J Physiol 277:C628–637

    PubMed  CAS  Google Scholar 

  37. Deckers MM, van Bezooijen RL, van der Horst G, Hoogendam J, van Der Bent C, Papapoulos SE, Lowik CW (2002) Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 143:1545–1553

    Article  PubMed  CAS  Google Scholar 

  38. Akeno N, Robins J, Zhang M, Czyzyk-Krzeska MF, Clemens TL (2002) Induction of vascular endothelial growth factor by IGF-I in osteoblast-like cells is mediated by the PI3K signaling pathway through the hypoxia-inducible factor-2α. Endocrinology 143:420–425

    Article  PubMed  CAS  Google Scholar 

  39. Kozawa O, Kawamura H, Hatakeyama D, Matsuno H, Uematsu T (2000) Endothelin-1 induces vascular endothelial growth factor synthesis in osteoblasts: involvement of p38 mitogen-activated protein kinase. Cell Signal 12:375–380

    Article  PubMed  CAS  Google Scholar 

  40. Wang DS, Yamazaki K, Nohtomi K, Shizume K, Ohsumi K, Shibuya M, Demura H, Sato K (1996) Increase of vascular endothelial growth factor mRNA expression by 1, 25-dihydroxyvitamin D3 in human osteoblast-like cells. J Bone Miner Res 11:472–479

    Article  PubMed  CAS  Google Scholar 

  41. Liu XH, Kirschenbaum A, Lu M, Yao S, Dosoretz A, Holland JF, Levine AC (2002) Prostaglandin E2 induces hypoxia-inducible factor-1α stabilization and nuclear localization in a human prostate cancer cell line. J Biol Chem 277:50081–50086

    Article  PubMed  CAS  Google Scholar 

  42. Chen M, Zhu M, Awad H, Li TF, Sheu TJ, Boyce BF, Chen D, O'Keefe RJ (2008) Inhibition of β-catenin signaling causes defects in postnatal cartilage development. J Cell Sci 121:1455–1465

    Article  PubMed  CAS  Google Scholar 

  43. Kaidi A, Williams AC, Paraskeva C (2007) Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol 9:210–217

    Article  PubMed  CAS  Google Scholar 

  44. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA (2003) Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88:873–884

    Article  PubMed  CAS  Google Scholar 

  45. Ai-Aql ZS, Alagl AS, Graves DT, Gerstenfeld LC, Einhorn TA (2008) Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 87:107–118

    Article  PubMed  CAS  Google Scholar 

  46. Choi IH, Ahn JH, Chung CY, Cho TJ (2000) Vascular proliferation and blood supply during distraction osteogenesis: a scanning electron microscopic observation. J Orthop Res 18:698–705

    Article  PubMed  CAS  Google Scholar 

  47. Danis A (2001) Mechanism of bone lengthening by the Ilizarov technique. Bull Mem Acad R Med Belg 156:107–112

    PubMed  CAS  Google Scholar 

  48. Glowacki J (1998) Angiogenesis in fracture repair. Clin Orthop Relat Res S82–S89

  49. Ferguson C, Alpern E, Miclau T, Helms JA (1999) Does adult fracture repair recapitulate embryonic skeletal formation? Mech Dev 87:57–66

    Article  PubMed  CAS  Google Scholar 

  50. Le AX, Miclau T, Hu D, Helms JA (2001) Molecular aspects of healing in stabilized and non-stabilized fractures. J Orthop Res 19:78–84

    Article  PubMed  CAS  Google Scholar 

  51. Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH (2002) Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 99:9656–9661

    Article  PubMed  CAS  Google Scholar 

  52. Bosch-Marce M, Okuyama H, Wesley JB, Sarkar K, Kimura H, Liu YV, Zhang H, Strazza M, Rey S, Savino L, Zhou YF, McDonald KR, Na Y, Vandiver S, Rabi A, Shaked Y, Kerbel R, Lavallee T, Semenza GL (2007) Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res 101:1310–1318

    Article  PubMed  CAS  Google Scholar 

  53. Liu L, Marti GP, Wei X, Zhang X, Zhang H, Liu YV, Nastai M, Semenza GL, Harmon JW (2008) Age-dependent impairment of HIF-1α expression in diabetic mice: correction with electroporation-facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells. J Cell Physiol 217:319–327

    Article  PubMed  CAS  Google Scholar 

  54. Cozen L (1972) Does diabetes delay fracture healing? Clin Orthop Relat Res 82:134–140

    Article  PubMed  CAS  Google Scholar 

  55. Loder RT (1988) The influence of diabetes mellitus on the healing of closed fractures. Clin Orthop Relat Res 210–216

  56. Maes C, Coenegrachts L, Stockmans I, Daci E, Luttun A, Petryk A, Gopalakrishnan R, Moermans K, Smets N, Verfaillie CM, Carmeliet P, Bouillon R, Carmeliet G (2006) Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair. J Clin Invest 116:1230–1242

    Article  PubMed  CAS  Google Scholar 

  57. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858–864

    Article  PubMed  CAS  Google Scholar 

  58. Kitaori T, Ito H, Schwarz EM, Tsutsumi R, Yoshitomi H, Oishi S, Nakano M, Fujii N, Nagasawa T, Nakamura T (2009) Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum 60:813–823

    Article  PubMed  CAS  Google Scholar 

  59. Ilizarov GA (1990) Clinical application of the tension–stress effect for limb lengthening. Clin Orthop Relat Res 8–26

  60. Wan C, Gilbert SR, Wang Y, Cao X, Shen X, Ramaswamy G, Jacobsen KA, Alaql ZS, Eberhardt AW, Gerstenfeld LC, Einhorn TA, Deng L, Clemens TL (2008) Activation of the hypoxia-inducible factor-1α pathway accelerates bone regeneration. Proc Natl Acad Sci U S A 105:686–691

    Article  PubMed  CAS  Google Scholar 

  61. Jacobsen KA, Al-Aql ZS, Wan C, Fitch JL, Stapleton SN, Mason ZD, Cole RM, Gilbert SR, Clemens TL, Morgan EF, Einhorn TA, Gerstenfeld LC (2008) Bone formation during distraction osteogenesis is dependent on both VEGFR1 and VEGFR2 signaling. J Bone Miner Res 23:596–609

    Article  PubMed  CAS  Google Scholar 

  62. Tarkka T, Sipola A, Jamsa T, Soini Y, Yla-Herttuala S, Tuukkanen J, Hautala T (2003) Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues. J Gene Med 5:560–566

    Article  PubMed  CAS  Google Scholar 

  63. Geiger F, Bertram H, Berger I, Lorenz H, Wall O, Eckhardt C, Simank HG, Richter W (2005) Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res 20:2028–2035

    Article  PubMed  CAS  Google Scholar 

  64. Huang YC, Kaigler D, Rice KG, Krebsbach PH, Mooney DJ (2005) Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 20:848–857

    Article  PubMed  CAS  Google Scholar 

  65. Geiger F, Lorenz H, Xu W, Szalay K, Kasten P, Claes L, Augat P, Richter W (2007) VEGF producing bone marrow stromal cells (BMSC) enhance vascularization and resorption of a natural coral bone substitute. Bone 41:516–522

    Article  PubMed  CAS  Google Scholar 

  66. Zelzer E, Mamluk R, Ferrara N, Johnson RS, Schipani E, Olsen BR (2004) VEGFA is necessary for chondrocyte survival during bone development. Development 131:2161–2171

    Article  PubMed  CAS  Google Scholar 

  67. Pfander D, Kobayashi T, Knight MC, Zelzer E, Chan DA, Olsen BR, Giaccia AJ, Johnson RS, Haase VH, Schipani E (2004) Deletion of Vhlh in chondrocytes reduces cell proliferation and increases matrix deposition during growth plate development. Development 131:2497–2508

    Article  PubMed  CAS  Google Scholar 

  68. Pfander D, Cramer T, Schipani E, Johnson RS (2003) HIF-1α controls extracellular matrix synthesis by epiphyseal chondrocytes. J Cell Sci 116:1819–1826

    Article  PubMed  CAS  Google Scholar 

  69. Robins JC, Akeno N, Mukherjee A, Dalal RR, Aronow BJ, Koopman P, Clemens TL (2005) Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9. Bone 37:313–322

    Article  PubMed  CAS  Google Scholar 

  70. Amarilio R, Viukov SV, Sharir A, Eshkar-Oren I, Johnson RS, Zelzer E (2007) HIF-1α regulation of Sox9 is necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis. Development 134:3917–3928

    Article  PubMed  CAS  Google Scholar 

  71. Tamiya H, Ikeda T, Jeong JH, Saito T, Yano F, Jung YK, Ohba S, Kawaguchi H, Chung UI, Choi JY (2008) Analysis of the Runx2 promoter in osseous and non-osseous cells and identification of HIF2A as a potent transcription activator. Gene 416:53–60

    Article  PubMed  CAS  Google Scholar 

  72. Deckers MM, Karperien M, van der Bent C, Yamashita T, Papapoulos SE, Lowik CW (2000) Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 141:1667–1674

    Article  PubMed  CAS  Google Scholar 

  73. Otomo H, Sakai A, Uchida S, Tanaka S, Watanuki M, Moriwaki S, Niida S, Nakamura T (2007) Flt-1 tyrosine kinase-deficient homozygous mice result in decreased trabecular bone volume with reduced osteogenic potential. Bone 40:1494–1501

    Article  PubMed  CAS  Google Scholar 

  74. Midy V, Plouet J (1994) Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem Biophys Res Commun 199:380–386

    Article  PubMed  CAS  Google Scholar 

  75. Mayr-Wohlfart U, Waltenberger J, Hausser H, Kessler S, Gunther KP, Dehio C, Puhl W, Brenner RE (2002) Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 30:472–477

    Article  PubMed  CAS  Google Scholar 

  76. Mayer H, Bertram H, Lindenmaier W, Korff T, Weber H, Weich H (2005) Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem 95:827–839

    Article  PubMed  CAS  Google Scholar 

  77. Villars F, Bordenave L, Bareille R, Amedee J (2000) Effect of human endothelial cells on human bone marrow stromal cell phenotype: role of VEGF? J Cell Biochem 79:672–685

    Article  PubMed  CAS  Google Scholar 

  78. Furumatsu T, Shen ZN, Kawai A, Nishida K, Manabe H, Oohashi T, Inoue H, Ninomiya Y (2003) Vascular endothelial growth factor principally acts as the main angiogenic factor in the early stage of human osteoblastogenesis. J Biochem 133:633–639

    Article  PubMed  CAS  Google Scholar 

  79. Peng H, Wright V, Usas A, Gearhart B, Shen HC, Cummins J, Huard J (2002) Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110:751–759

    PubMed  CAS  Google Scholar 

  80. Okuyama H, Krishnamachary B, Zhou YF, Nagasawa H, Bosch-Marce M, Semenza GL (2006) Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1. J Biol Chem 281:15554–15563

    Article  PubMed  CAS  Google Scholar 

  81. Nakagawa M, Kaneda T, Arakawa T, Morita S, Sato T, Yomada T, Hanada K, Kumegawa M, Hakeda Y (2000) Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett 473:161–164

    Article  PubMed  CAS  Google Scholar 

  82. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87:3336–3343

    PubMed  CAS  Google Scholar 

  83. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD, Nishikawa S (1990) The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345:442–444

    Article  PubMed  CAS  Google Scholar 

  84. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ (1999) Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A 96:3540–3545

    Article  PubMed  CAS  Google Scholar 

  85. Niida S, Kaku M, Amano H, Yoshida H, Kataoka H, Nishikawa S, Tanne K, Maeda N, Nishikawa S, Kodama H (1999) Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med 190:293–298

    Article  PubMed  CAS  Google Scholar 

  86. Niida S, Kondo T, Hiratsuka S, Hayashi S, Amizuka N, Noda T, Ikeda K, Shibuya M (2005) VEGF receptor 1 signaling is essential for osteoclast development and bone marrow formation in colony-stimulating factor 1-deficient mice. Proc Natl Acad Sci U S A 102:14016–14021

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Alabama at Birmingham, 1670 University Boulevard, G001, Birmingham, AL, 35294, USA

    Ryan C. Riddle & Thomas L. Clemens

  2. Veterans Administration Medical Center, Birmingham, AL, USA

    Thomas L. Clemens

  3. Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

    Richa Khatri & Ernestina Schipani

Authors
  1. Ryan C. Riddle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richa Khatri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ernestina Schipani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Thomas L. Clemens
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas L. Clemens.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Riddle, R.C., Khatri, R., Schipani, E. et al. Role of hypoxia-inducible factor-1α in angiogenic–osteogenic coupling. J Mol Med 87, 583–590 (2009). https://doi.org/10.1007/s00109-009-0477-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-009-0477-9

Keywords

Search

Navigation